AG Information Network of the West looks at GLP-1 users' effect on protein demand, alongside news on a US trade deal with Mexico.
Recap by typeshit. Full story at AG INFORMATION NETWORK OF THE WEST.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
HHS is proposing temporary enforcement priorities and side effect reporting for compounded peptides, with more specifics in Becker's rundown.
Eric Fry sees upside on Wegovy pill demand, while Zacks expects 2026 revenue and EPS to fall. The FDA call on CagriSema is expected in Q4 2026.
Loading…